It has been demonstrated that CD34+ leukemia stem cells display a high level of autophagic flux, and, more importantly, TKI treatment, as the flip side, stimulates autophagy responsible for leukemia stem cell survival and establishment of drug resistance (Bellodi et al., 2009). This evidence concerns the gene CD34 and leukemia.